WO1993010793A1 - Agent antiviral - Google Patents

Agent antiviral Download PDF

Info

Publication number
WO1993010793A1
WO1993010793A1 PCT/RU1992/000170 RU9200170W WO9310793A1 WO 1993010793 A1 WO1993010793 A1 WO 1993010793A1 RU 9200170 W RU9200170 W RU 9200170W WO 9310793 A1 WO9310793 A1 WO 9310793A1
Authority
WO
WIPO (PCT)
Prior art keywords
virus
sρedsτvο
dηκ
pροτivοviρusnοe
chτο
Prior art date
Application number
PCT/RU1992/000170
Other languages
English (en)
Russian (ru)
Inventor
Jury Petrovich Vainberg
Elli Nikolaevna Kaplina
Original Assignee
Jury Petrovich Vainberg
Elli Nikolaevna Kaplina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jury Petrovich Vainberg, Elli Nikolaevna Kaplina filed Critical Jury Petrovich Vainberg
Publication of WO1993010793A1 publication Critical patent/WO1993010793A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Un agent antiviral contient une substance active, un complexe d'un sel de sodium d'ADN natif avec un métal polyvalent choisi parmi Ni, Fe, Co, Mn, Mg ou Zn pris à un rapport molaire de 10-1000:0,5-3,0, respectivement, et un diluant pharmaceutique. L'agent de l'invention a une activité virale contre le virus herpétique, l'orthomyxo-virus - virus de la grippe, le paramyxo-virus - virus de la peste des carnivores, et contre des rétrovirus, y compris le virus de l'immunodéficience humaine.
PCT/RU1992/000170 1991-12-03 1992-09-09 Agent antiviral WO1993010793A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SU5015754/14 1991-12-03
SU5015754 1991-12-03

Publications (1)

Publication Number Publication Date
WO1993010793A1 true WO1993010793A1 (fr) 1993-06-10

Family

ID=21591133

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU1992/000170 WO1993010793A1 (fr) 1991-12-03 1992-09-09 Agent antiviral

Country Status (1)

Country Link
WO (1) WO1993010793A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0818202A1 (fr) * 1994-09-29 1998-01-14 Nauchno-Proizvodstvennoe Predpriyatie "Farmek" Hybride d'adn-arn et preparation d'adn, procedes d'obtention dudit hybride et de ladite preparation a partir de laitance d'esturgeon, et compose pharmaceutique a base dudit hybride d'adn-arn
WO2002043740A1 (fr) * 2000-12-01 2002-06-06 Veritas S.R.L. Procede de fabrication d'un produit antiviral immunotropique

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135312A2 (fr) * 1983-07-27 1985-03-27 Pharmaceuticals Limited Scotia Compositions antivirales
FR2598619A1 (fr) * 1986-05-16 1987-11-20 Mafitra Management Services In Medicament antiviral a base d'acide nucleique modifie, et son procede de preparation
DE3724951A1 (de) * 1987-07-28 1989-02-09 Werner E G Prof Dr Mueller Arzneimittel, enthaltend modifizierte desoxyribonukleinsaeure und dessen verwendung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135312A2 (fr) * 1983-07-27 1985-03-27 Pharmaceuticals Limited Scotia Compositions antivirales
FR2598619A1 (fr) * 1986-05-16 1987-11-20 Mafitra Management Services In Medicament antiviral a base d'acide nucleique modifie, et son procede de preparation
DE3724951A1 (de) * 1987-07-28 1989-02-09 Werner E G Prof Dr Mueller Arzneimittel, enthaltend modifizierte desoxyribonukleinsaeure und dessen verwendung

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0818202A1 (fr) * 1994-09-29 1998-01-14 Nauchno-Proizvodstvennoe Predpriyatie "Farmek" Hybride d'adn-arn et preparation d'adn, procedes d'obtention dudit hybride et de ladite preparation a partir de laitance d'esturgeon, et compose pharmaceutique a base dudit hybride d'adn-arn
EP0818202A4 (fr) * 1994-09-29 2000-05-10 Npp Farmek Hybride d'adn-arn et preparation d'adn, procedes d'obtention dudit hybride et de ladite preparation a partir de laitance d'esturgeon, et compose pharmaceutique a base dudit hybride d'adn-arn
WO2002043740A1 (fr) * 2000-12-01 2002-06-06 Veritas S.R.L. Procede de fabrication d'un produit antiviral immunotropique
EP1338281A4 (fr) * 2000-12-01 2004-03-24 Veritas S R L Procede de fabrication d'un produit antiviral immunotropique

Similar Documents

Publication Publication Date Title
US5523232A (en) Use of restriction endonucleases against viruses, including HIV
US6093702A (en) Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
EP0601164B1 (fr) Procedes pour le traitement d'infections virales
WO1992021368A1 (fr) Composition et procede de traitement de maladies
EP0630644A4 (fr) Compose pharmaceutique anti-microbien et induisant des interferons.
AU2006212322A1 (en) Use of iron(III) complex compounds
Bocci et al. The clinical application of ozonetherapy
CN104127402A (zh) 双环铂在制备抗病毒药物和抗菌药物中的应用
McKINLAY et al. Prevention of human poliovirus-induced paralysis and death in mice by the novel antiviral agent arildone
DE60032915T2 (de) Gallium komplexe von 3-hydroxy-4-pyronen zur behandlung von durch intrazelluläre prokaryoten, dns- und retro-viren verursachten infektionen
EP0804227B1 (fr) Utilisation de dimere de lysozyme pour traiter le cancer
WO2003072124A1 (fr) Methode d'induction de differentiation cellulaire
WO1993010793A1 (fr) Agent antiviral
MXPA06013050A (es) Composiciones a base de compuestos inmunoreguladores para el tratamiento o prevencion de infecciones virales respiratorias.
EA003100B1 (ru) Лечебный препарат вирулицидного действия
JPH06199697A (ja) 抗ウイルス・抗菌・殺菌剤
MELLERT et al. Inhibition of HIV-1 replication by an antiviral xanthate compound in vitro
EP0236487A1 (fr) Inactivation d'un virus
EP0255420A2 (fr) Agent antiviral d'inhibition de la croissance du virus du syndrome immuno-deficitaire acquis (SIDA)
RU2440128C1 (ru) Способ комплексной патогенетической терапии острых форм вирусного гепатита в и микст-гепатитов (в+с, в+d, в+с+d)
RU2264819C2 (ru) Фармацевтическая противогерпетическая композиция и способ получения лекарственной формы на ее основе
RU2182828C1 (ru) Композиция, обладающая антивич и антигерпесной активностью
RU2005475C1 (ru) Противовирусное средство
JPH06199694A (ja) 血圧安定化治療剤
RU2697887C1 (ru) Средство, обладающее противовирусным действием в отношении вирусов клещевого энцефалита и герпеса простого I типа

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA